April 1, 2020 / 11:37 AM / 4 months ago

BRIEF-Stealth Biotherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights

April 1 (Reuters) - Stealth BioTherapeutics Corp:

* STEALTH BIOTHERAPEUTICS REPORTS FISCAL YEAR 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

* STEALTH BIOTHERAPEUTICS CORP - GUIDANCE ON REGULATORY PATH FOR BARTH SYNDROME EXPECTED MIDYEAR 2020

* STEALTH BIOTHERAPEUTICS CORP - COMPLETION OF PHASE 2B DRY AMD STUDY ENROLLMENT EXPECTED BY SECOND HALF 2020

* STEALTH BIOTHERAPEUTICS SEES COMPLETE ENROLLMENT OF PHASE 2B STUDY IN DRY AMD DURING H2 OF THIS YEAR, KEEPING CO ON-TRACK FOR H2 2021 TOP-LINE READ-OUT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below